当前位置:首页 - 行情中心 - 威尔药业(603351) - 财务分析

威尔药业

(603351)

  

流通市值:37.23亿  总市值:37.23亿
流通股本:1.35亿   总股本:1.35亿

威尔药业(603351)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年第一季度实现净利润0.36亿元,每股收益0.27元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年第一季度最新股东权益174448.70万元,未分配利润59228.63万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年第一季度最新总资产242399.17万元,负债67950.46万元。

利润表
报告期2025-03-312024-12-312024-09-302024-06-30
营业总收入349,725,188.551,296,753,389.061,000,364,429.23688,157,870.31
营业总成本307,861,914.391,137,417,233.03886,687,537.69606,291,744.8
营业利润43,019,332.36172,350,437.39128,898,149.7494,704,582.48
利润总额42,949,715.49172,131,263.87128,731,004.4794,631,739.53
净利润35,766,178.54145,205,838.7111,031,186.377,713,250.39
其他综合收益----
综合收益总额35,766,178.54145,205,838.7111,031,186.377,713,250.39
资产负债表
报告期2025-03-312024-12-312024-09-302024-06-30
流动资产合计734,995,021.33717,205,052.03599,216,567.22655,614,702.88
非流动资产合计1,688,996,630.371,663,708,867.641,680,220,842.311,689,763,661.07
资产总计2,423,991,651.72,380,913,919.672,279,437,409.532,345,378,363.95
流动负债合计583,245,290.13595,900,957.25516,054,200.84618,014,866.4
非流动负债合计96,259,346.5576,814,704.8387,546,924.4596,308,182.53
负债合计679,504,636.68672,715,662.08603,601,125.29714,323,048.93
归属于母公司股东权益合计1,739,034,006.51,701,923,864.461,670,212,016.141,624,746,926.84
股东权益合计1,744,487,015.021,708,198,257.591,675,836,284.241,631,055,315.02
负债和股东权益合计2,423,991,651.72,380,913,919.672,279,437,409.532,345,378,363.95
现金流量表
报告期2025-03-312024-12-312024-09-302024-06-30
经营活动现金流入小计268,677,131.121,099,680,714.3842,784,174.82547,538,192.13
经营活动现金流出小计246,465,675.22877,887,268.84681,578,988.5470,618,201.44
经营活动产生的现金流量净额22,211,455.9221,793,445.46161,205,186.3276,919,990.69
投资活动现金流入小计900,0009,976,968.548,569,933.366,559,883.11
投资活动现金流出小计50,525,198.8380,457,885.174,075,153.9857,168,274.26
投资活动产生的现金流量净额-49,625,198.83-70,480,916.56-65,505,220.62-50,608,391.15
筹资活动现金流入小计121,000,000381,020,400242,886,361.11202,000,000
筹资活动现金流出小计97,395,728.17444,052,234.79326,903,030.08213,274,002.55
筹资活动产生的现金流量净额23,604,271.83-63,031,834.79-84,016,668.97-11,274,002.55
汇率变动对现金及现金等价物的影响-2,456.451,373,441.63636,376.69630,869.37
现金及现金等价物净增加额-3,811,927.5589,654,135.7412,319,673.4215,668,466.36
期末现金及现金等价物余额243,388,554.83247,200,482.38169,866,020.06173,214,813
最新报告期:2025-02-18
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
申万宏源张静含,李敏杰1.371.74--2025-02-18
TOP↑